No data are available about the amount of hepatitis B virus (HBV) genomes in liver of patients with chronic HBV infection. The aim of this study was to quantify the intrahepatic HBV DNA in hepatitis B surface antigen (HBsAg)-positive patients with either active or suppressed viral replication and in
Chronic hepatitis B virus (HBV) infection in pregnancy
โ Scribed by Hui-Hui Tan; Hock-Foong Lui; Wan-Cheng Chow
- Book ID
- 107593762
- Publisher
- Springer-Verlag
- Year
- 2008
- Tongue
- English
- Weight
- 153 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1936-0533
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
In a previous study a partial inhibition of viral replication was observed in HBeAg-positive patients after acyclovir (ACV) treatment. To assess those results and to evaluate different treatment regimens, a randomized controlled trial with ACV given at 45 mg/kg/day by continuous infusion (in 5 pati
to be controlled for in comparing immunoprophylactic approaches. At present, DNA polymerase activity or HBV DNA is useful for estimating the level of exposure. In an editorial in this issue, Dr. Dienstag pointed out difficulties in comparing the results of two immunoprophylactic regimens conducted a
Integrated hepatitis B virus (HBV) DNA sequences were found in neoplastic liver tissue of a hepatitis B surface antigen (HBsAg)-negative child who had previously suffered from HBsAg-positive chronic active hepatitis and was anti-HBs and antihepatitis B core (HBc) positive at the time of tumor develo